QYOBO (qyobo.com)

QYOBO (qyobo.com) — Global pharmaceutical manufacturing-site graph resolved to site granularity: for each facility — what it produces (including specific APIs), its technologies and dosage-form capabilities (sterile production, films, patches, highly potent APIs, monoclonal antibodies, beta-lactam antibiotics), its ownership chain consolidated across subsidiaries with public/private status and private-equity acquisition timing and position in the investment cycle, its compliance history and certifications by region (EU GMP, ANVISA and others), its geographic exposure to hazards such as immine…

QYOBO (qyobo.com) offers (Alternative, Supply Chain, Reference, Fundamental) — Claims coverage of 'every manufacturing site worldwide' — implying a global facility universe in the tens of thousands of pharmaceutical and API manufacturing sites, each with product, capability, ownership, certification and dependency linkages, plus an ongoing classified event stream. No record count is published; site, edge and event totals must be requested from the vendor before pricing..

Pharma supply-chain concentration and single-point-of-failure analysis (the site-to-market dependency edges are the core asset and are extremely hard to assemble publicly); reshoring and capacity-gap analysis by region and capability; M&A target screening for facilities available for acquisition, with PE cycle position as a timing signal; shortage-prediction models seeded from event-to-site-to-product attribution; geographic hazard exposure scoring for manufacturing portfolios; private-credit and equity due diligence on manufacturer assets; and training graph models on the site-product-owner-event structure.

The data is with 3 years of history.

Coverage spans Europe, Other, US, UK, APAC, China/HK; Pharmaceuticals, Application Software; alternative, supply_chain, reference, fundamental; equities, fixed_income.